Natasha Schenk

437 total citations
7 papers, 348 citations indexed

About

Natasha Schenk is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Natasha Schenk has authored 7 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Genetics and 2 papers in Molecular Biology. Recurrent topics in Natasha Schenk's work include Bone health and treatments (6 papers), Estrogen and related hormone effects (6 papers) and Cancer, Lipids, and Metabolism (2 papers). Natasha Schenk is often cited by papers focused on Bone health and treatments (6 papers), Estrogen and related hormone effects (6 papers) and Cancer, Lipids, and Metabolism (2 papers). Natasha Schenk collaborates with scholars based in United States, Australia and Belgium. Natasha Schenk's co-authors include J. Miller, Antonio Llombart‐Cussac, Gϋnter von Minckwitz, Holger Eidtmann, Nigel Bundred, N. Davidson, P. Neven, Robert E. Coleman, Richard de Boer and Patrick Neven and has published in prestigious journals such as Cancer Research, Annals of Oncology and Cancer Discovery.

In The Last Decade

Natasha Schenk

7 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Natasha Schenk United States 6 316 159 102 67 64 7 348
Jungsil Ro South Korea 5 258 0.8× 79 0.5× 16 0.2× 18 0.3× 29 0.5× 6 299
Anna Maria Vandone Italy 8 314 1.0× 18 0.1× 114 1.1× 103 1.5× 104 1.6× 21 405
M. Campone France 8 128 0.4× 16 0.1× 14 0.1× 86 1.3× 12 0.2× 21 217
Hans Wildiers Belgium 4 189 0.6× 50 0.3× 14 0.1× 79 1.2× 3 0.0× 10 233
CE Geyer United States 9 217 0.7× 74 0.5× 5 0.0× 71 1.1× 54 0.8× 23 262
A. Stopeck United States 9 242 0.8× 56 0.4× 12 0.1× 80 1.2× 4 0.1× 20 295
Dooreh Kim South Korea 10 120 0.4× 30 0.2× 5 0.0× 32 0.5× 12 0.2× 38 262
J.M. Vannetzel France 7 112 0.4× 26 0.2× 3 0.0× 114 1.7× 46 0.7× 10 220
Tetsuhiro Yoshinami Japan 6 116 0.4× 18 0.1× 5 0.0× 53 0.8× 11 0.2× 48 174

Countries citing papers authored by Natasha Schenk

Since Specialization
Citations

This map shows the geographic impact of Natasha Schenk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natasha Schenk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natasha Schenk more than expected).

Fields of papers citing papers by Natasha Schenk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natasha Schenk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natasha Schenk. The network helps show where Natasha Schenk may publish in the future.

Co-authorship network of co-authors of Natasha Schenk

This figure shows the co-authorship network connecting the top 25 collaborators of Natasha Schenk. A scholar is included among the top collaborators of Natasha Schenk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natasha Schenk. Natasha Schenk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Ryan, Meagan B., Bradley Quade, Natasha Schenk, et al.. (2024). The Pan-RAF–MEK Nondegrading Molecular Glue NST-628 Is a Potent and Brain-Penetrant Inhibitor of the RAS–MAPK Pathway with Activity across Diverse RAS- and RAF-Driven Cancers. Cancer Discovery. 14(7). 1190–1205. 16 indexed citations
2.
Eidtmann, Holger, Richard de Boer, Nigel Bundred, et al.. (2010). Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study. Annals of Oncology. 21(11). 2188–2194. 229 indexed citations
3.
4.
Eidtmann, Holger, N.J. Bundred, Rebecca DeBoer, et al.. (2009). The effect of zoledronic acid on aromatase inhibitor associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36 months follow-up of ZO-FAST.. Cancer Research. 69(2_Supplement). 44–44. 48 indexed citations
5.
6.
7.
Davidson, N., Patrick Neven, Antonio Llombart‐Cussac, et al.. (2005). P105 Zoledronic acid in the prevention of cancer treatment-induced bone loss in postmenopausal women receiving letrozole as adjuvant therapy for early breast cancer. The Breast. 14. S44–S44. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jungsil Ro Breakdown of academic impact, for papers by Anna Maria Vandone Breakdown of academic impact, for papers by M. Campone Breakdown of academic impact, for papers by Hans Wildiers Breakdown of academic impact, for papers by CE Geyer Breakdown of academic impact, for papers by A. Stopeck Breakdown of academic impact, for papers by Dooreh Kim Breakdown of academic impact, for papers by J.M. Vannetzel Breakdown of academic impact, for papers by Tetsuhiro Yoshinami
Rankless by CCL
2026